Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.
about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentGlycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionCytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionThe regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients.Recognition of tumors by the innate immune system and natural killer cells.Natural killer cell-mediated shedding of ULBP2.PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells.The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsImmunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicityExpression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours.Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cellsNK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function declineComprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer.Combination immune therapies to enhance anti-tumor responses by NK cells.NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.Shaping of NK cell responses by the tumor microenvironmentGeneration of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.Advances in NKG2D ligand recognition and responses by NK cells.TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.Exploiting natural killer group 2D receptors for CAR T-cell therapy.IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo.NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AMLOxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity.Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients.Role of Distinct Natural Killer Cell Subsets in Anticancer Response.Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study.Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity.Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.
P2860
Q26751011-382EF57B-84D6-4BEF-A629-211C97599412Q28073613-FBDDB4F2-A320-4738-B863-5D08DA98792FQ28076151-3822A600-23F7-4951-B386-A302E94BDAA3Q30648415-71CEF707-A0E2-4C3B-8138-1D72A8299113Q33761979-DDA2BDEC-EE84-42CE-8633-9A42A4E7DDAFQ34068134-1EDB142F-112F-46D1-B011-81E56E2D2BECQ34496462-7098E047-6688-4CD7-ACEF-F97B10F0FB8EQ35116691-CE1D5F64-0C46-450D-9A6D-52239BD1D174Q35163691-7A0904C3-1067-430E-A2A1-DAAF3D8E64EAQ35566828-7E3072D8-0D5D-48EF-839D-6C722A1B3589Q36238117-D45BC8DA-0EB1-466A-8F06-152D72F93691Q36278732-7BB3DD15-681E-47AF-AA96-3C673A79E3D9Q36989586-2E47982C-DBAC-498F-AA7A-A36F63706E16Q37077413-7C44114F-CB9B-40DA-A486-D8388627463FQ37081973-5B4F0B89-EFC6-4694-9D7C-E9CDDB3E9D7FQ37137278-97BA9B2A-F7EF-412E-B191-10DA792ED5ADQ37155165-BE750A42-0A90-42AA-80D9-A57F54E0CB80Q37194949-D82D14A8-3B90-4C7C-BCE5-30D0AC97F192Q37316220-6F96F72F-7CA9-4EFB-ACF0-3831ADD7B45DQ37370451-165B1FD3-B330-4024-A176-F94150716661Q37408550-43AAFA84-ACBD-4F69-BB8A-AAB346CF1E71Q37708827-B161BD96-9071-476A-B81D-3D894B865138Q37743484-B72E7387-85B3-4BD8-9A35-8102927AF3A7Q38067641-D52CF3A8-AFA8-44EE-A153-F006F5F1CB69Q38107250-4AAA8536-3B4E-4B7D-90CB-6E5A4B699A9DQ38180339-1379550F-24D8-4F27-829A-9A777C71C579Q38286095-A7B9151B-3C55-427A-8AB8-85101E30E4C8Q38671184-70C9E71D-8843-41C7-B501-6386C2725B72Q38839145-1601C21E-A9B3-4BC9-9FD4-58523F764482Q38847073-96A546B5-E078-424F-AEC9-D3F318C1EB11Q38857163-39E23311-0610-4322-AC9E-8A463F1ACAADQ38930242-F7167FF5-F899-4B5F-BE09-ED59E85A9C0FQ38940720-BA54C56C-256F-4E13-A0A8-CFE37D8D3D87Q39159252-3554478D-9661-497B-9B32-71B695D373A8Q39185522-765437BB-2FCD-4D13-A998-277EF41917EBQ39210022-579B1B03-5D60-4235-8545-1BB63A596DEEQ39296861-D979076F-81EC-4F1E-BEC4-AC12F484D90FQ40215861-8328F6A9-DB6D-48DB-B3D5-EE4472307E8CQ40372471-022E2329-5C47-4626-BAC9-D5AA20490A8EQ40679442-059FCC30-B57B-433B-BEED-3C3E11714B4B
P2860
Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Comprehensive analysis of NKG2 ...... 2D-mediated NK cell responses.
@en
Comprehensive analysis of NKG2 ...... 2D-mediated NK cell responses.
@nl
type
label
Comprehensive analysis of NKG2 ...... 2D-mediated NK cell responses.
@en
Comprehensive analysis of NKG2 ...... 2D-mediated NK cell responses.
@nl
prefLabel
Comprehensive analysis of NKG2 ...... 2D-mediated NK cell responses.
@en
Comprehensive analysis of NKG2 ...... 2D-mediated NK cell responses.
@nl
P2093
P356
P1476
Comprehensive analysis of NKG2 ...... G2D-mediated NK cell responses
@en
P2093
Corina Buechele
Frank Grünebach
Helmut Rainer Salih
Julia Hilpert
Ludger Grosse-Hovest
Tina Nuebling
Tobias Raum
P304
P356
10.4049/JIMMUNOL.1200796
P407
P577
2012-06-22T00:00:00Z